IPOs
– The advanced cell therapy for chronic wound therapy company pricing of the shares at $10 was well below the $13-15 range that the...
Hi, what are you looking for?
– The advanced cell therapy for chronic wound therapy company pricing of the shares at $10 was well below the $13-15 range that the...
– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing...
– Estee Lauder is not just another pretty face among stocks; bulls are ready for some upside ahead of its report next month. Pete...
Marc Benioff’s Salesforce.com made an 8-K regulatory filing with the Securities and Exchange Commission on Friday, indicating it had entered into an agreement by...
– The Tel-Aviv Stock Exchange (TASE) and Eurex Exchange, the international derivatives marketplace and part of Deutsche Börse Group, announced today during a...
This week: Mingling at the Microsoft Ventures Tel Aviv Accelerator The success of start-up accelerators like Y Combinator, Tech Stars and DreamIt has spawned...
– In our last post, we talked about why people invest and gave you some ideas about the shortcomings of traditional thinking in the...
– James Simons / Bloomberg – /By Clive Minchom / Last week Bloomberg reported that the United States Internal Revenue Service has been attacking...
– Can-Fite Ceo Pnina Fishman – /By Ilan Shavit/ Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin Board: CANFY) has obtained a patent from the US Patent and...
– – / By Clive Minchom / We reported last week that that Steven Cohen, Chairman and founder of giant hedge fund SAC Capital...